Featured Speaker: Will Singleterry, PhD, Director of Business Development, IsoPlexis
In this Webinar we discuss:
Evaluate T cell responses induced by various bispecific T cell engagers across phenotypes
Understand the heterogeneity of TIL polyfunctionality in solid tumors in response to checkpoint inhibitors
Uniquely correlate clinical anti-tumor responses with IsoPlexis data
Optimize combination cancer vaccines in melanoma using model systems
Access related webinars, eBooks, app notes & case studies.